Page last updated: 2024-08-24

delphinidin and Bone Loss, Osteoclastic

delphinidin has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Imangali, N; Mahady, G; Phan, QT; Winkler, C1
Inoue, F; Into, T; Moriwaki, S; Muramatsu, M; Niida, S; Nomura, A; Suzuki, K; Yoshiko, Y1

Other Studies

2 other study(ies) available for delphinidin and Bone Loss, Osteoclastic

ArticleYear
The dietary anthocyanin delphinidin prevents bone resorption by inhibiting Rankl-induced differentiation of osteoclasts in a medaka (Oryzias latipes) model of osteoporosis.
    Journal of fish biology, 2021, Volume: 98, Issue:4

    Topics: Animals; Animals, Genetically Modified; Anthocyanins; Bone and Bones; Bone Resorption; Cell Differentiation; Diet; Dietary Supplements; Disease Models, Animal; Macrophages; Oryzias; Osteoclasts; Osteogenesis; Osteoporosis; RANK Ligand; Signal Transduction

2021
Delphinidin, one of the major anthocyanidins, prevents bone loss through the inhibition of excessive osteoclastogenesis in osteoporosis model mice.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Administration, Oral; Animals; Anthocyanins; Blueberry Plants; Bone Resorption; Cell Line; Female; Mice; Mice, Inbred C57BL; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteoporosis; Proto-Oncogene Proteins c-fos; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; X-Ray Microtomography

2014